image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5491
-5 %
$ 66.2 M
Market Cap
-1.02
P/E
BALANCE SHEET
31.7 M ASSETS
123.16%
24.2 M LIABILITIES
34.65%
7.43 M EQUITY
295.09%
BALANCE SHEET DECOMPOSITION
Balance Sheet Unicycive Therapeutics, Inc.
image
Current Assets 30.9 M
Cash & Short-Term Investments 26.1 M
Receivables 0
Other Current Assets 4.81 M
Non-Current Assets 720 K
Long-Term Investments 0
PP&E 720 K
Other Non-Current Assets 0
82.55 %15.18 %Total Assets$31.7m
Current Liabilities 24.1 M
Accounts Payable 966 K
Short-Term Debt 564 K
Other Current Liabilities 22.6 M
Non-Current Liabilities 117 K
Long-Term Debt 117 K
Other Non-Current Liabilities 0
3.99 %93.20 %Total Liabilities$24.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 26.1 9.7 0.5 16.6 0 15 K 25 K
Short Term Investments 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 4.8 3.7 2.2 1.8 0.2 4 K 4 K
Total Current Assets 30.9 13.4 2.6 18.4 0.2 19 K 29 K
PP&E 0.7 0.8 0.2 0.3 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0 0 (0.2) (0.3) 0.2 0 0
Other Assets 0 0 0 0 (0.2) 0 0
Total Assets 31.7 14.2 2.8 18.7 0.2 19 K 29 K
LIABILITIES
Accounts Payable 1.0 0.8 0.8 0.7 0.2 0.3 60 K
Short Term Debt 0.6 0.3 0.3 0.3 2.5 0.5 1.0
Other Current Liabilities 22.5 16.4 2.1 1.1 0.2 0.1 0.1
Total Current Liabilities 24.1 17.5 3.3 2.1 2.9 0.9 1.2
Long Term Debt 0.1 0.5 0 0.2 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0
Total Liabilities 24.2 18.0 3.3 2.3 2.9 0.9 1.2
EQUITY
Common Stock 0.1 35 K 15 K 15 K 9 K 8 K 34 K
Retained Earnings (101.3) (64.5) (34.0) (15.9) (5.9) (3.7) (1.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0
Total Equity 7.4 (3.8) (0.5) 16.5 (2.7) (0.9) (1.2)
Total Liabilities and Equity 31.7 14.2 2.8 18.7 0.2 19 K 29 K
SHARES OUTSTANDING
Common Shares Outstanding 669.9 24.5 15.1 15.0 15.2 8.4 7.9